EUCTR2012-005636-29-BG进行中（未招募）不适用
3-Year, Observational Study to Evaluate the Durability of Sustained Viral Response and the Kinetics of Antiviral-Resistant HCV in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 183
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To participate in the study, subjects must meet all of the following inclusion criteria:
- •1.Read and signed the written informed consent form (ICF) after the nature of the study has been fully explained.
- •2.Participation in an Idenix-sponsored study of an Idenix DAA.
- •3.Received at least 3 consecutive days of DAA treatment in an Idenix-sponsored study.
- •4.Agreed to comply with the visit schedule and laboratory tests.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 183
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects will be excluded from the study if they meet any of the following exclusion criteria:
- •1.Treatment with placebo only, in an Idenix-sponsored study.
- •2.Antiviral treatment for HCV after participation in an Idenix-sponsored study of an Idenix DAA.
研究者
相似试验
进行中（未招募）
1 期
A Long-Term Follow-up Study to Evaluate Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical Trial.Hepatitis C Virus Infection (HCV).MedDRA version: 14.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-002232-85-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.3,250
进行中（未招募）
1 期
A Long-Term Follow-up Study to Evaluate Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical TrialHepatitis C Virus Infection (HCV)MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-002232-85-SEMerck Sharp & Dohme Corp.350
进行中（未招募）
1 期
MK-5172 Protocol 017 Long-term Follow Up StudyEUCTR2012-002232-85-GRMerck Sharp & Dohme Corp.3,250
进行中（未招募）
1 期
A Long-Term Follow-up Study looking at the Virologic Response (checking a patient's blood to ensure that there is no detectable virus) and/or Viral Resistance (checking that the virus has not changed in anyway which might mean that treatment is no longer effective) of Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical TrialHepatitis C Virus Infection (HCV)MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-002232-85-GBMerck Sharp & Dohme Corp.2,435
进行中（未招募）
1 期
A Long-Term Follow-up Study to Evaluate Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical TrialEUCTR2012-002232-85-ESMerck Sharp & Dohme Corp.3,250